Committee backs mandatory sickle‑cell continuing education after moving testimony from patients
Summary
SB 844 would require a one‑time, two‑hour board‑approved continuing education course on sickle cell disease care management for certain licensed clinicians at initial licensure or renewal. Testimony included moving first‑person accounts from patients and families detailing delayed care, bias and avoidable complications in emergency settings.
Sen. Jones introduced SB 844 to add a one‑time, two‑hour continuing education requirement for licensed physicians and nurses on sickle cell disease care management as part of initial licensure or renewal. The course must be board‑approved and cover evidence‑based treatment protocols across the life course, pain management, genetic counseling, psychosocial care, and family education. Jones and public witnesses emphasized that many clinicians receive little formal training on sickle cell disease and that standardized education would reduce mistreatment, delayed care, and preventable complications.
Public testimony included emotional, direct accounts: 12‑year‑old Shamara Harper described fear of seeking emergency care and asked lawmakers to pass SB 844 so children would receive faster, competent pain treatment; multiple adult speakers and advocates documented instances of mismanagement, labeling as 'drug seekers,' and structural neglect that led to worse outcomes. Several speakers and organizations urged passage; the committee reported the bill favorably as a committee substitute.
Next steps: SB 844 will proceed through the legislative process; implementation would require board approval of curricula and placement in initial licensing and renewal processes.
